Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DGAT2L7P is annotated as a pseudogene associated with the diacylglycerol O-acyltransferase 2-like family. Pseudogenes are DNA sequences that resemble functional genes but are generally not transcribed or translated into active proteins, and therefore have no direct biological activity or disease association. Some confusion may arise because closely related genes such as DGAT2L6 and DGAT2 (protein-coding) are involved in acyltransferase activity important for triglyceride synthesis and may have disease relevance, but DGAT2L7P itself does not encode a protein nor participate in biological pathways[2]. Pseudogenes are sometimes misidentified as targets or referenced in error in drug target lists; this entry is best excluded from functional databases and drug discovery lists. In summary, DGAT2L7P is not a therapeutic target, has no proven biological function, and is considered a non-coding genomic fragment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diacylglycerol O-acyltransferase 2 like 7, pseudogene (DGAT2L7P).